BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 2406802)

  • 1. Early detection of connective tissue disease in patients with Raynaud's phenomenon.
    Kallenberg CG
    Rheum Dis Clin North Am; 1990 Feb; 16(1):11-30. PubMed ID: 2406802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raynaud's phenomenon as an early sign of connective tissue diseases.
    Kallenberg CG
    Vasa Suppl; 1992; 34():25-8. PubMed ID: 1529414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution of Raynaud's phenomenon: a longterm prospective study.
    Luggen M; Belhorn L; Evans T; Fitzgerald O; Spencer-Green G
    J Rheumatol; 1995 Dec; 22(12):2226-32. PubMed ID: 8835553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
    Schlager O; Kiener HP; Stein L; Hofkirchner J; Zehetmayer S; Ristl R; Perkmann T; Smolen JS; Koppensteiner R; Gschwandtner ME
    Scand J Rheumatol; 2014; 43(3):226-33. PubMed ID: 24517537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.
    Williams HJ; Alarcon GS; Joks R; Steen VD; Bulpitt K; Clegg DO; Ziminski CM; Luggen ME; St Clair EW; Willkens RF; Yarboro C; Morgan JG; Egger MJ; Ward JR
    J Rheumatol; 1999 Apr; 26(4):816-25. PubMed ID: 10229402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. An analysis of patterns discriminating patients with and without connective tissue disease.
    Houtman PM; Kallenberg CG; Fidler V; Wouda AA
    J Rheumatol; 1986 Jun; 13(3):556-63. PubMed ID: 3735277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
    Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
    Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.
    Pavlov-Dolijanovic S; Damjanov NS; Stojanovic RM; Vujasinovic Stupar NZ; Stanisavljevic DM
    Rheumatol Int; 2012 Oct; 32(10):3039-45. PubMed ID: 21901350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.
    Kallenberg CG; Wouda AA; Hoet MH; van Venrooij WJ
    Ann Rheum Dis; 1988 Aug; 47(8):634-41. PubMed ID: 3261966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raynaud's features in childhood. Clinical, immunological and capillaroscopic study.
    Navon P; Yarom A; Davis E
    J Mal Vasc; 1992; 17(4):273-6. PubMed ID: 1494054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.
    Groen H; Wichers G; ter Borg EJ; van der Mark TW; Wouda AA; Kallenberg CG
    Am J Med; 1990 Jul; 89(1):34-41. PubMed ID: 2368791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function in patients presenting with Raynaud's phenomenon without an underlying connective tissue disease. A prospective, longitudinal study.
    Aalbers R; Groen H; Postma DS; Van der Mark TW; Wouda AA; Reig RP; Kallenberg CG
    J Rheumatol; 1989 Jan; 16(1):36-41. PubMed ID: 2785598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.
    Yunus MB; Hussey FX; Aldag JC
    J Rheumatol; 1993 Sep; 20(9):1557-60. PubMed ID: 8164214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
    Passiu G; Sebastiani GD; Galeazzi M; Tuveri MA; Nicosia PM; Boirivant R
    Medicina (Firenze); 1990; 10(4):405-7. PubMed ID: 2099984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Need to expand microvascular investigation of patients with Raynaud's phenomenon of different etiology: clinical patterns of 106 consecutive patients.
    Arpaia G; Cimminiello C; Bellone M; Aloisio M; Rossi F; Bonfardeci G
    Int Angiol; 1994 Mar; 13(1):15-8. PubMed ID: 8077792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary microscopy is a potential screening method for connective tissue disease in children with Raynaud's phenomenon.
    Farenhorst CA; Roon AM; Gessel AI; Stel AJ; Bootsma H; Armbrust W; Mulder DJ
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):11. PubMed ID: 35135560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO; Russell AS
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.